Advances in Journal of Clinical Immunology
Editor-in-Chief Chiguang Feng is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Journal of Clinical Immunology and Research (JCIR) is a web based, open-access, interdisciplinary peer-reviewed broad scope journal that publishes high impact papers in the area of human immunology that explore the diagnosis, pathogenesis, prognosis, or treatment of human diseases. The Journal is particularly focused on primary immune deficiencies and related diseases. These include inborn errors of immunity, in the broad sense of the term, their underlying genotypes, and their diverse phenotypes, including infection, malignancy, allergy, auto-inflammation, and autoimmunity.
JCIR will accept the following types of manuscript: Research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication. All submitted material is subjected to a strict peer-review process. All correspondence, including notification of the Editor's decision (or) review comments and requests for revision, takes place by e-mail.
How we work:
- After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
- A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
- Author proof is generated within 7 working days after the acceptance decision.